Skip to main content
. 2020 Aug 3;73(3):e531–e539. doi: 10.1093/cid/ciaa1143

Figure 3.

Figure 3.

Decrease in NAb levels in patients with COVID-19. A, Comparison of NAb levels between the peak point and the follow-up time point 2. B, Percentage decrease in NAbs in patients with COVID-19. Abbreviations: COVID-19, coronavirus disease 2019; ID50, 50% inhibitory dose; NAb, neutralizing antibody; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.